Arrowhead Pharmaceuticals, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $105.3M | $349.8M | $221.8M |
| FY2020 | $60.7M | $522.5M | $143.6M |
| FY2021 | $301.3M | $710.1M | $184.4M |
| FY2022 | $293.4M | $691.9M | $108.0M |
| FY2023 | $494.2M | $765.6M | $110.9M |